These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36652659)

  • 1. Multishell Colloidosome Platform with Sequential Gastrointestinal Resistance for On-Demand Probiotic Delivery.
    Xie X; Li Q; Jia L; Yuan H; Guo T; Meng T
    Adv Healthc Mater; 2023 May; 12(12):e2202954. PubMed ID: 36652659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteria-Induced Colloidal Encapsulation for Probiotic Oral Delivery.
    Zhang C; Gao X; Ren X; Xu T; Peng Q; Zhang Y; Chao Z; Jiang W; Jia L; Han L
    ACS Nano; 2023 Apr; 17(7):6886-6898. PubMed ID: 36947056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotic Gastrointestinal Transit and Colonization After Oral Administration: A Long Journey.
    Han S; Lu Y; Xie J; Fei Y; Zheng G; Wang Z; Liu J; Lv L; Ling Z; Berglund B; Yao M; Li L
    Front Cell Infect Microbiol; 2021; 11():609722. PubMed ID: 33791234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in microencapsulation of probiotics: A review.
    Yao M; Xie J; Du H; McClements DJ; Xiao H; Li L
    Compr Rev Food Sci Food Saf; 2020 Mar; 19(2):857-874. PubMed ID: 33325164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colonization of C57BL/6 Mice by a Potential Probiotic Bifidobacterium bifidum Strain under Germ-Free and Specific Pathogen-Free Conditions and during Experimental Colitis.
    Grimm V; Radulovic K; Riedel CU
    PLoS One; 2015; 10(10):e0139935. PubMed ID: 26439388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient protection of microorganisms for delivery to the intestinal tract by cellulose sulphate encapsulation.
    Gunzburg WH; Aung MM; Toa P; Ng S; Read E; Tan WJ; Brandtner EM; Dangerfield J; Salmons B
    Microb Cell Fact; 2020 Nov; 19(1):216. PubMed ID: 33243224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards effective and stable probiotics.
    Yarullina DR; Damshkaln LG; Bruslik NL; Konovalova OA; Ilinskaya ON; Lozinsky VI
    Int J Risk Saf Med; 2015; 27 Suppl 1():S65-6. PubMed ID: 26639716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semi-Rational Screening of Probiotics from the Fecal Flora of Healthy Adults against DSS-Induced Colitis Mice by Enhancing Anti-Inflammatory Activity and Modulating the Gut Microbiota.
    Wang W; Xing W; Wei S; Gao Q; Wei X; Shi L; Kong Y; Su Z
    J Microbiol Biotechnol; 2019 Sep; 29(9):1478-1487. PubMed ID: 30270604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiologically Inspired Mucin Coated
    Yang X; Yang J; Ye Z; Zhang G; Nie W; Cheng H; Peng M; Zhang K; Liu J; Zhang Z; Shi J
    ACS Nano; 2022 Mar; 16(3):4041-4058. PubMed ID: 35230097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of bacteria in experimental colitis.
    Guarner F; Malagelada JR
    Best Pract Res Clin Gastroenterol; 2003 Oct; 17(5):793-804. PubMed ID: 14507589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of probiotics with different functions alleviate DSS-induced colitis by regulating intestinal microbiota, IL-10, and barrier function.
    Wang Y; Xie Q; Zhang Y; Ma W; Ning K; Xiang JY; Cui J; Xiang H
    Appl Microbiol Biotechnol; 2020 Jan; 104(1):335-349. PubMed ID: 31758237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotics (Lactobacillus plantarum HNU082) Supplementation Relieves Ulcerative Colitis by Affecting Intestinal Barrier Functions, Immunity-Related Gene Expression, Gut Microbiota, and Metabolic Pathways in Mice.
    Wu Y; Jha R; Li A; Liu H; Zhang Z; Zhang C; Zhai Q; Zhang J
    Microbiol Spectr; 2022 Dec; 10(6):e0165122. PubMed ID: 36321893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preserving viability of Lactobacillus rhamnosus GG in vitro and in vivo by a new encapsulation system.
    Li R; Zhang Y; Polk DB; Tomasula PM; Yan F; Liu L
    J Control Release; 2016 May; 230():79-87. PubMed ID: 27063422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR γ to suppress colitis.
    Bassaganya-Riera J; Viladomiu M; Pedragosa M; De Simone C; Carbo A; Shaykhutdinov R; Jobin C; Arthur JC; Corl BA; Vogel H; Storr M; Hontecillas R
    PLoS One; 2012; 7(2):e31238. PubMed ID: 22363592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral nanozyme-engineered probiotics for the treatment of ulcerative colitis.
    Zhao H; Du Y; Liu L; Du Y; Cui K; Yu P; Li L; Zhu Y; Jiang W; Li Z; Tang H; Ma W
    J Mater Chem B; 2022 Jun; 10(21):4002-4011. PubMed ID: 35503001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Encapsulation on The Stability of Probiotic Bacteria in Ice Cream and Simulated Gastrointestinal Conditions.
    Afzaal M; Saeed F; Arshad MU; Nadeem MT; Saeed M; Tufail T
    Probiotics Antimicrob Proteins; 2019 Dec; 11(4):1348-1354. PubMed ID: 30426464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The viability of Lactobacillus fermentum CECT5716 is not essential to exert intestinal anti-inflammatory properties.
    Rodríguez-Nogales A; Algieri F; Vezza T; Garrido-Mesa N; Olivares M; Comalada M; Riccardi C; Utrilla MP; Rodríguez-Cabezas ME; Galvez J
    Food Funct; 2015 Apr; 6(4):1176-84. PubMed ID: 25700085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the alleviation effects of a combination of Lactobacillus rhamnosus and inulin on mice with colitis.
    Liu Z; Liu F; Wang W; Sun C; Gao D; Ma J; Hussain MA; Xu C; Jiang Z; Hou J
    Food Funct; 2020 May; 11(5):3823-3837. PubMed ID: 32329478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of engineered probiotics with tailored functional properties and their application in food science.
    Pramanik S; Venkatraman S; Vaidyanathan VK
    Food Sci Biotechnol; 2023 Mar; 32(4):453-470. PubMed ID: 36911322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomaterial-based encapsulation for controlled gastrointestinal delivery of viable probiotic bacteria.
    Razavi S; Janfaza S; Tasnim N; Gibson DL; Hoorfar M
    Nanoscale Adv; 2021 May; 3(10):2699-2709. PubMed ID: 36134186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.